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The primary clinical role of the non-invasive
physical measurement of a bone, generally
referred to as ‘bone densitometry,’ is to identify
those subjects at risk of an osteoporotic fracture
and their subsequent response to pharmaceuti-
cal intervention. The true ‘gold standard’ mea-
surement of the mechanical integrity of a bone,
and hence its fracture load, is a destructive test,
generally performed by compressing either a reg-
ular shaped sample or whole bone, as shown in
figure 1. 
A number of bone densitometry techniques have been
developed and utilised, effectively serving as surrogates for
fracture load prediction. Most are based upon x-ray mea-
surements of density and utilising attenuation of electro-
magnetic photons by calcium atoms; and hence dependent
upon the bone mineral content (BMC). We may record areal
bone mineral density (BMD, g cm–2) by dividing the BMC
by the projected scan area, the depth of tissue propagated
being unknown. We may record volumetric bone density
(apparent, g cm–3) by dividing BMC by the volume of tissue
measured. It is generally accepted that these bone densito-
metry techniques predict true mechanical integrity with an
accuracy of approximately 40-75%, for example,1 the remain-
ing portion being explained by the term ‘bone quality’, pre-
dominantly indicating bone shape and cancellous bone
structure. There is increasing interest therefore in develop-
ing and utilising techniques that measure, or are dependent
upon, the external shape and internal structure of a bone,
either independently or in combination with bone density.
Areal BMD from absorptiometry assessment 
The conventional method of assessing osteoporosis in the
clinical environment is bone mineral density (BMD), an
areal parameter with measurement units of g cm–2, describ-
ing the bone mineral within a projected area. There is, how-
ever, a terminology confusion since the World Health
Organisation (WHO) has also used the term ‘osteoporosis’
to define a BMD T-score (number of young normal standard
deviations a subject’s BMD value is compared with average
young normal mean value) threshold of -2.5; and creating
a new term of ‘osteopenia’ to describe moderate bone loss
with a T-score between -1 and -2.5. The term ‘established
osteoporosis’ is used when the BMD score is ‘osteoporotic’
and the subject has suffered a fracture – meeting both
‘osteoporosis’ definitions in effect! 
Routine quantitative BMD assessment was first achieved
by measuring the transmission absorption of a highly colli-
mated photon beam from a single-energy radionuclide source
(SPA), such as 125I or 241Am; thereby overcoming the prob-
lems associated with radiographic absorption caused by poly-
chromatic x-rays and non-uniformity of film sensitivity and
development. To correct for overlying soft tissue, the
anatomical site being measured was generally immersed in
a water bath; hence, the distal radius and calcaneus were
generally measured. The shortcomings of SPA were super-
seded by low-dose single-energy x-ray absorptiometry (SXA),
providing a greater photon flux and hence reduced mea-
surement time, improved spatial resolution and precision,
in addition to removing the requirement for radio-isotope
source replacement. The need for constant thickness of the
photon pathway restricted the use of SXA/SPA to periph-
eral sites and they could not be applied to important frac-
ture sites such as the spine and hip because of widely
varying soft tissue thickness and soft tissue composition. 
Dual photon absorptiometry (DPA) techniques were 
introduced to overcome the restriction of constant overall
thickness of measurement site, generally utilising 153Gd.
Dual-energy absorptiometry analysis is based upon the solu-
tion of two simultaneous equations, one describing the trans-
mitted intensity of ‘low’ energy and the other of ‘high energy’
photons, thereby deriving the areal bone density. This analy-
sis assumes, however, that the human body is a two-com-
ponent system, specifically bone mineral and a particular
lean-fat composition of soft tissue defined by the ‘R-factor’.
During a BMD measurement, it is assumed that the soft-tis-
sue overlaying the bone has the same R-factor as the tis-
sue adjacent to the bone; this explains why a ‘soft tissue’
region of interest (ROI) measurement is recorded during a
BMD assessment scan.
As with SXA replacing SPA, dual x-ray absorptiometry
(DXA) has replaced DPA, noting that the fundamental 
scientific basis behind DPA and DXA are identical, the main
advantages of DXA over DPA again being shortened exam-
ination time due to an increased photon fluence of the 
x-ray tube and greater accuracy and precision resulting from
higher resolution and removal of errors due to source decay.
The preferred anatomic sites for DXA measurement of bone
mineral include the osteoporotic fracture sites of lumbar
spine, proximal femur and distal radius along with whole-
body assessment. figure 2 illustrates typical DXA-derived
BMD scans of the lumbar spine, proximal femur and distal
radius.
Volumetric density from absorptiometry assessment
Measurement of true volumetric bone density (g cm–3), along
with the cross-sectional area of separate trabecular and cor-
tical bone components may be derived using quantitative
computed tomography (QCT), the attenuation again being
by elemental calcium. QCT utilises a conventional x-ray CT
scanner and calibration phantom that generally consists of
a number of rods, each of varying volumetric bone density.
The 3D CT data set consists of a series of congruent 2D
images, each consisting of an array of elements termed vox-
els, whose individual dimensions are determined by the
scanner spatial resolution and ‘slice’ thickness. The grey-
level of each voxel is first converted into Hounsfield Units
using standardised values for different tissues. The corre-
sponding bone mineral content is then determined via the
calibration phantom that is scanned adjacent to the subject,
shown in figure 3a. Dividing this by the corresponding tis-
sue volume yields the volumetric density. QCT is being used
increasingly, particularly at the lumbar spine, although
there is a higher radiation dose associated with QCT than
DXA. Unlike areal bone mineral density, QCT density mea-
surements are independent of bone size and thus is a more
robust measure for comparisons of bone density between
populations and potentially for growing children as well.
Somewhat surprisingly to the author, QCT is becoming
increasingly used to replicate areal BMD measurements,
which may be considered a retrograde step, going from 3D
information back to 2D information – one assumes that this
demonstrates the power of clinical expectation and under-
standing; people are comfortable with DXA-derived BMD
despite its known limitations. Comparative cost is an inter-
esting aspect; proponents of DXA will highlight the high
running costs of a CT scanner, QCT proponents will claim
that no additional hardware is required, only the calibra-
tion phantom and analysis software. 
The high capital and running costs associated with con-
ventional CT scanner QCT assessment of volumetric bone
density assessment has prompted the development of dedi-
cated peripheral-QCT (pQCT) systems specifically for sepa-
rate volumetric density measurement of trabecular and
cortical components at the distal radius and proximal tibia,
shown in figure 3b. pQCT inherently delivers a lower dose
to the patient than standard spinal QCT since only the
peripheral skeleton is irradiated. As a comparison, the effec-
tive dose received from a spinal QCT is approximately
60 µSv, being far greater than that of DXA (~1 µSv). The
effective dose for a typical pQCT exam is comparable with
spinal DXA (< 2 µSv). pQCT is often therefore used for
detailed assessment of children. 
Quantitative ultrasound
Quantitative ultrasound (QUS) utilises high frequency sound
waves to measure how much sound is absorbed by the bone,
generally referred to as Broadband Ultrasound Attenuation
(BUA, dB MHz–1), or how quickly sound travels through
bone termed velocity ( m s–1). Due to technical difficulties,
ultrasound measurements cannot to date be performed at
the common anatomical sites affected by osteoporosis (spine,
hip and wrist). However, it has been clinically demonstrated
that BUA measurement of the calcaneus (heel) provides an
accurate indication of osteoporosis fracture risk, particularly
for hip fracture. BUA measures the linear increase in ultra-
sound attenuation with frequency (dB/MHz) and, contrary to
the previous photon absorptiometry techniques, the primary
attenuation mechanism is related to structure not degree of
mineralisation. Ultrasound velocity measurements may be
taken at a number of additional anatomical sites including
the phalanges and tibia. There is a well defined fundamen-
tal relationship that links ultrasound velocity with both the
elasticity and density of a material such as bone. Images
are not generally obtained by QUS systems. 
Ultrasound systems are of significantly lower cost that
x-ray based techniques such as DXA and QCT and, since
they do not utilise ionising radiation, have often been
installed within a ‘high street’ environment independent of
an integrated healthcare programme. Additionally, there is
a lack of uniformity of reported BUA measurements, fur-
ther exacerbated by their creation of proprietary parame-
ters, often combining BUA and velocity measurements
aimed at providing the best prediction of BMD. To make
matters worse, there has been a false assumption that
BMD-based T-scores may be applied to ultrasound. All of
these factors have contributed and combined to effectively
discredit ultrasound, which is a great shame, particularly
since the initial aims proposed for the technique were either
independent fracture risk assessment or a triage measure-
ment within a formal integrated healthcare system. In sum-
mary, the true value of ultrasound has not to date been
realised. 
Magnetic resonance imaging
A technique that is gaining increasing interest is magnetic
resonance imaging (MRI) which essentially measures the
water content of tissues. Although a signal is not obtained
from bone, by subtracting the signal obtained from bone
marrow, a three-dimensional volumetric image of trabecular
structure may be obtained, as shown in figure 4a. The
physical basis of MRI is complex but is based upon the fact
that water molecules contain two hydrogen protons that
have what is termed a ‘magnetic dipole moment’ that spin
(precess) similar to a spinning top. We may align the central
axis of all of these spinning magnetic dipoles using a high
strength magnetic field. We may then add an oscillating
(radio-frequency, RF) magnetic field that has the same
(Larmour) frequency as the spinning rate of the magnetic
dipoles, that makes the angle of spin have a certain value,
which may be 180 degrees, ie spinning within a plane nor-
mal to the central axis. When the RF field is switched off,
the spinning magnetic dipoles return to their original spin-
ning angle, but in doing so, release energy of a certain
amount and at a certain rate. There are number of para-
meters that may describe this process; the T1 time constant
is related to ‘axial magnetisation,’ the T2 time constant is
related to ‘transverse magnetisation’ and the T2* magnetic
field inhomogeneity-induced relaxation time. A contrast
agent such as gadolinium may be injected into the patient. 
MRI may also be utilised to quantify the composition of
bone marrow, shown in figure 4b, thought by the author to
be an important parameter associated with bone remodelling
and osteoporosis.
Beyond bone density
A number of numerical analysis techniques have recently
been described that offer the potential to serve as mechan-
ical integrity surrogates superior to conventional areal and
volumetric bone density assessment. An enhancement of
DXA-derived BMD is Hip Strength Analysis (HSA) based
upon a combination of cross-sectional area and cross-sec-
tional moment of inertia, yielding an improvement in pre-
diction of proximal femur strength from 62% for femoral
neck BMD to 79% for HSA in an experimental study of 20
femora.2 The ability of a stereo-radiographic technique, based
upon biplanar acquisitions for reconstruction of the proxi-
mal femur, to predict failure load of the human proximal
femur was experimentally tested in a stance-loading config-
uration; failure load was predicted by total hip BMD with R2
= 41%, which increased significantly to 84% when a multi-
ple linear regression model was considered, additionally
incorporating femoral head diameter and mid-femoral neck
cross-sectional area.3
Finite Element Analysis (FEA) is a computer simulation
technique that can predict the deformation of a structure
such as a bone when a load is applied, providing a measure
of mechanical stiffness (N mm–1). FEA of the proximal
femur, for example, is therefore inherently dependent on
the overall size and shape of the bone (hip axis length, neck-
shaft angle, anteversion of femoral head, etc), which is
described by the geometry of the elements and on the mate-
rial properties applied to each element. A number of studies,
over a significant number of years, have reported the utility
of 3D FEA based upon CT image data to predict the
mechanical integrity of the proximal femur.4 However,
because of the high costs and high radiation dose, CT scans
are not routinely used in clinical assessment of osteoporosis.
DXA, on the other hand, is relatively easier and less expen-
sive to obtain. A FEA technique based upon a single DXA
image has recently been reported that provided a 50%
improvement in predicted fracture load as assessed by con-
ventional BMD.5
In conclusion, we have to hand a plethora of different
‘bone densitometry’ techniques but often lose sight of what
we are fundamentally trying to achieve, namely identifica-
tion and monitoring of subjects at risk of an osteoporotic
fracture through surrogates of mechanical integrity.
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FIGURE 4
a) MRI image of bone structure at the wrist. b) MRI




a) QCT assessment of the
lumbar spine using soft-
ware developed by the
author. 






Experimental compression testing of a proximal
femur in a) a stance and b) a fall loading scenario.
FIGURE 2
Typical DXA-derived BMD scans of the lumbar spine,
proximal femur and distal radius.
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